C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1

Exp Neurol. 2009 Dec;220(2):255-66. doi: 10.1016/j.expneurol.2009.08.029. Epub 2009 Sep 6.

Abstract

To assess potential efficacy of mechano growth factor (MGF) for chronic neurodegenerative disorders, we studied whether MGF protects dopamine (DA) neurons subjected to neurotoxic stress. We show that a short 24-amino acid C-terminal peptide of MGF (MGF24) upregulates heme oxygenase-1 (HO-1) expression and protects SH-SY5Y cells against apoptosis and cell loss induced by three DA cell-specific neurotoxins: 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenylpyridinium (MPP(+)), and rotenone. MGF24 maintains the mitochondrial membrane potential and blocks the release of mitochondrial apoptotic-inducing factor into the cytoplasm induced by 6-OHDA, MPP(+), and rotenone. Chemical inhibition of HO-1 with zinc protoporphyrin-IX prevents neuroprotection by MGF24 against the three neurotoxins. MGF24 does not activate Akt signaling nor does Akt inhibition block MGF24 protection of SH-SY5Y cells. In 6-OHDA-lesioned rats, central or peripheral MGF24 administration protects against the development of contralateral forelimb under-utilization, reduces ipsilateral nigral DA cell body loss, and attenuates tyrosine hydroxylase fiber loss in the ipsilateral striatum, independent of IGF-1 receptor activation. Peripheral MGF24 administration upregulates HO-1 expression in striatal and midbrain tissue. This report is the first to demonstrate that a small peptide, MGF24, upregulates HO-1, an important cell defense mediator, and protects DA cells, suggesting new strategies for neuroprotection in Parkinson's disease.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Line
  • DNA Fragmentation / drug effects
  • Dopamine / physiology*
  • Enzyme Induction / drug effects
  • Heme Oxygenase-1 / biosynthesis*
  • Insulin-Like Growth Factor I / metabolism
  • Membrane Potentials / drug effects
  • Mitochondrial Membranes / drug effects
  • Neostriatum / drug effects
  • Neostriatum / metabolism
  • Neurons / drug effects*
  • Neurons / enzymology
  • Neuroprotective Agents*
  • Oxidopamine / toxicity
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • STAT5 Transcription Factor / pharmacology*
  • Signal Transduction / drug effects
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism
  • Sympatholytics / toxicity
  • Tetrazolium Salts
  • Thiazoles
  • Tumor Suppressor Proteins / pharmacology*
  • Up-Regulation / drug effects

Substances

  • Neuroprotective Agents
  • STAT5 Transcription Factor
  • STAT5A protein, human
  • Sympatholytics
  • Tetrazolium Salts
  • Thiazoles
  • Tumor Suppressor Proteins
  • Insulin-Like Growth Factor I
  • Oxidopamine
  • Heme Oxygenase-1
  • Proto-Oncogene Proteins c-akt
  • thiazolyl blue
  • Dopamine